Skip to main content

ONCOZ · OncoZenge AB

3.5150 SEK +0.0650 (+1.88%) At close · Oct 2
Market Cap
84.67M SEK
Shares
25.05M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Investor day
Close3.5150 SEK Open3.5450 SEK Day3.3900–3.7850 SEK 52W close3.1950–8.3600 SEK Avg vol 30d73K Last earningsNov 18, 2027 DataFeb 2021–Oct 2026

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 3.1950 SEK Now 3.5150 SEK · 6% Range high 8.3600 SEK
vs 200-day avg -40% vs 50-day avg -26%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
FNSE:ONCOZ +4.0% -1.8% -40.2% +1.9% -48.0%

Exchange listing

Market
FNSE
Ticker
ONCOZ
ISIN
SE0015504097
Security
—
Trading currency
SEK

Company

Other listings of this company

No other verified listings are available.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

DateEventType
2026-11-11 00:00 UTC Interim Report for January-September 2026 Results publication
2027-02-18 00:00 UTC Year-End Report 2026 Results publication
2027-04-22 00:00 UTC Annual Report for 2026 Event
2027-05-20 00:00 UTC Interim Report Jan-Mar 2027 Results publication
2027-08-26 00:00 UTC Interim Report Jan - Jun 2027 Results publication
2027-11-18 00:00 UTC Interim Report Jan - Sep 2027 Results publication

Earnings calls

  • Earnings call · Q3 2027 2027-11-18 Scheduled
    Interim Report Jan - Sep 2027
  • Earnings call · Q2 2027 2027-08-26 Scheduled
    Interim Report Jan - Jun 2027
  • Earnings call · Q1 2027 2027-05-20 Scheduled
    Interim Report Jan-Mar 2027
  • Earnings call · Q4 2026 2027-02-18 Scheduled
    Year-End Report 2026
  • Earnings call · Q3 2026 2026-11-11 Scheduled
    Interim Report for January-September 2026
  • Earnings call · Q2 2026 2026-08-27
    Interim Report for January-June 2026
  • Earnings call · Q1 2026 2026-05-26
    Interim Report for January-March 2026
  • Earnings call · Q4 2025 2026-02-26
    Full Year Report January – December 2025